Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Roslindale, Massachusetts Clinical Trials

A listing of Roslindale, Massachusetts clinical trials actively recruiting patient volunteers.

RESULTS

Found (642) clinical trials

A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression

This is an open-label (the researchers and participants know the treatment the participant is receiving) long-term extension study. The study will consist of 2 open-label Phases: 4-week Induction phase (if applicable) and Open-Label Optimization/Maintenance phase (variable). Participants will enter the study Induction Phase from ESKETINTRD3001 (NCT02417064), ESKETINTRD3002 (NCT02418585), ESKETINTRD3003 (NCT02493868), ...

Phase

0.0 miles

Learn More »

Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)

The purpose of this study is to compare the psychometric properties (performance validity) of 8 individual cognitive tests in a computer-administered cognitive test battery intended for the assessment of cognitive function in participants with major depressive disorder (MDD) either in partial or full remission against 8 corresponding standard, non-reference, examineradministered ...

Phase N/A

0.0 miles

Learn More »

Efficacy Safety and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.

Phase

0.13 miles

Learn More »

Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer

A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) as measured by overall response rate (ORR). The study will also evaluate safety and pharmacokinetics of INC280.

Phase

0.13 miles

Learn More »

If so, call Boston Clinical Trials at 617-477-4868 and ask about our research study of investigational medication for depression. Located in Roslindale Village.Evening appointments available.Free parking. Compensation provided. www.bostontrials.com

Phase N/A

0.13 miles

Learn More »

Boston Clinical Trials is conducting a study with an investigational medication for the treatment of migraine. Qualified participants will receive free study-related exams and study medication. Compensation provided. For more details, please call (617) 477-4868 Free parking, next to public transportation, evening appointments available.

Phase N/A

0.13 miles

Learn More »

Taking medication to treat depression, but still feel Down? No interest in activities? Loss of energy? Boston Clinical Trials is conducting a new clinical reaserch study of an Investigational drug for DEPRESSION. Compensation may be provided to qualified participants. Call today (617) 477-4868 or email studies@bostontrials.com For more information visit ...

Phase N/A

0.13 miles

Learn More »

Do you have uncomfortable bloating? Feeling gassy all the time? Having less than 3 bowel movements in a week? You might have irritable bowel syndrome. You may qualify to participate in a research study at Boston Clinical Trials with new investigational medication for irritable bowel syndrome with constipation. (IBS-C)

Phase

0.13 miles

Learn More »

Concerned about low libido? New clinical research study for post menopausal women enrolling now. Contact BCT for more info!

Phase N/A

0.13 miles

Learn More »

A Study to Compare the Efficacy Safety and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

The purpose of this study is to assess the efficacy of flexibly dosed JNJ-42847922 (20 milligram [mg] or 40 mg) compared to flexibly dosed quetiapine extended-release (XR) (150 mg or 300 mg) as adjunctive therapy to an antidepressant drug in delaying time to all-cause discontinuation of study drug over a ...

Phase

0.13 miles

Learn More »